Impaired long-term anti-HBs responses in choronic hepatitis C patients: Results from a five-year follow-up study with healthy control

References

• WHO. Global hepatitis report. Geneva (Switzerland): World Health Organization; 2017 [accessed 2018 Jul 17]. http://apps.who.int/iris/bitstream/handle/10665/255016/9789241565455-eng.pdf?sequence=1.
   Google Scholar
• Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, Abu-Raddad LJ, Assadi R, Bhala N, Cowie B, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet (London, England). 2016;388:1081–9. doi:10.1016/S0140-6736(16)30579-7.
   PubMed Web of Science ®Google Scholar
• Yu G, Chi X, Wu R, Wang X, Gao X, Kong F, Feng X, Gao Y, Huang X, Jin J, et al. Replication inhibition of hepatitis B virus and hepatitis C virus in co-infected patients in Chinese population. PloS One. 2015;10:e0139015. doi:10.1371/journal.pone.0139015.
   PubMed Web of Science ®Google Scholar
• Liaw YF, Yeh CT, Tsai SL. Impact of acute hepatitis B virus superinfection on chronic hepatitis C virus infection. Am J Gastroenterol. 2000;95:2978–80. doi:10.1111/j.1572-0241.2000.02337.x.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Hepatitis B vaccines: WHO position paper, July 2017 – recommendations. Vaccine. 2019;37:223–25. doi:10.1016/j.vaccine.2017.07.046.
   PubMed Web of Science ®Google Scholar
• Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology (Baltimore, MD). 2009;49:1335–74. doi:10.1002/hep.22759.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recommend Rep 1998;47:1–39.
   Google Scholar
• Cui FQ. Technical guide for adult hepatitis B immunization in China. Zhonghua Liu Xing Bing Xue Za Zhi (Chinese). 2011;32:1199–203.
   PubMedGoogle Scholar
• Liu J, Wu H, Chen H. Immune response to hepatitis B vaccine in patients with chronic hepatitis C infection: a systematic review and meta-analysis. Hepatol Res. 2018;48(2):119–26. doi:10.1111/hepr.13008.
   PubMed Web of Science ®Google Scholar
• Moorman JP, Zhang CL, Ni L, Ma CJ, Zhang Y, Wu XY, Thayer P, Islam TM, Borthwick T, Yao ZQ. Impaired hepatitis B vaccine responses during chronic hepatitis C infection: involvement of the PD-1 pathway in regulating CD4(+) T cell responses. Vaccine. 2011;29:3169–76. doi:10.1016/j.vaccine.2011.02.052.
   PubMed Web of Science ®Google Scholar
• Chlabicz S, Grzeszczuk A, Łapiński TW. Hepatitis B vaccine immunogenicity in patients with chronic HCV infection at one year follow-up: the effect of interferon-alpha therapy. Med Sci Monit. 2002;8:Cr379–83.
   PubMed Web of Science ®Google Scholar
• Bruce MG, Bruden D, Hurlburt D, Morris J, Bressler S, Thompson G, Lecy D, Rudolph K, Bulkow L, Hennessy T, et al. Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose. Hepatology. 2022;76:1180–189. doi:10.1002/hep.32474.
   PubMed Web of Science ®Google Scholar
• Kato M, Hamada-Tsutsumi S, Okuse C, Sakai A, Matsumoto N, Sato M, Sato T, Arito M, Omoteyama K, Suematsu N, et al. Effects of vaccine-acquired polyclonal anti-HBs antibodies on the prevention of HBV infection of non-vaccine genotypes. J Gastroenterol. 2017;52:1051–63. doi:10.1007/s00535-017-1316-3.
   PubMed Web of Science ®Google Scholar
• Liu J, Qiu S, Lu J, Yan B, Feng Y, Li L, Zhang G, Wang F, He P, Fang X, et al. Robust antibody and cytokine response to hepatitis B vaccine among not-in-treatment patients with chronic hepatitis C: an open-label control study in China. J Infect Dis. 2017;216:327–35. doi:10.1093/infdis/jix295.
   PubMed Web of Science ®Google Scholar
• Lucey DR, Clerici M, Shearer GM. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev. 1996;9:532–62. doi:10.1128/CMR.9.4.532.
   PubMed Web of Science ®Google Scholar
• Zhou B. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Zhonghua Liu Xing Bing Xue Za Zhi (Chinese). 2002;23:5–10.
   PubMedGoogle Scholar
• Chlabicz S, Lapinski TW, Grzeszczuk A, Prokopowicz D. Four-year follow up of hepatitis C patients vaccinated against hepatitis B virus. World J Gastroenterol. 2005;11:1798–801. doi:10.3748/wjg.v11.i12.1798.
   PubMed Web of Science ®Google Scholar
• Leroy V, Bourliere M, Durand M, Abergel A, Tran A, Baud M, Botta-Fridlund D, Gerolami A, Ouzan D, Halfon P, et al. The antibody response to hepatitis B virus vaccination is negatively influenced by the hepatitis C virus viral load in patients with chronic hepatitis C: a case–control study. Eur J Gastroenterol Hepatol. 2002;14:485–89. doi:10.1097/00042737-200205000-00004.
   PubMed Web of Science ®Google Scholar
• Wiedmann M, Liebert UG, Oesen U, Porst H, Wiese M, Schroeder S, Halm U, Mössner J, Berr F. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. Hepatology (Baltimore, MD). 2000;31:230–34. doi:10.1002/hep.510310134.
   PubMed Web of Science ®Google Scholar
• Idilman R, De MN, Colantoni A, Nadir A, Van Thiel DH. The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C. Am J Gastroenterol. 2002;97:435–39. doi:10.1111/j.1572-0241.2002.05482.x.
   PubMed Web of Science ®Google Scholar
• Greenbaum E, Nir-Paz R, Linton DM, Ben-Hur T, Meirovitz A, Zakay-Rones Z. Severe influenza infection in a chronic hepatitis C carrier: failure of protective serum HI antibodies after IM vaccination. J Clin Virol. 2004;29:23–26. doi:10.1016/S1386-6532(03)00194-X.
   PubMed Web of Science ®Google Scholar
• Chigbu DI, Loonawat R, Sehgal M, Patel D, Jain P. Hepatitis C virus infection: host–virus interaction and mechanisms of viral persistence. Cells. 2019;8:376. doi:10.3390/cells8040376.
   PubMed Web of Science ®Google Scholar
• Fallahi P, Ferri C, Ferrari SM, Corrado A, Sansonno D, Antonelli A. Cytokines and HCV-related disorders. Clin Dev Immunol. 2012;2012:468107. doi:10.1155/2012/468107.
   PubMedGoogle Scholar
• Xu Y, Zhong J. Innate immunity against hepatitis C virus. Curr Opin Immunol. 2016;42:98–104. doi:10.1016/j.coi.2016.06.009.
   PubMed Web of Science ®Google Scholar
• Fallahi P, Ferrari SM, Giuggioli D, Sebastiani M, Colaci M, Ferri C, Antonelli A. Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection and HCV extrahepatic manifestations. Curr Drug Targets. 2017;18:786–93. doi:10.2174/1389450116666150804105937.
   PubMed Web of Science ®Google Scholar
• Yao ZQ, Moorman JP. Immune exhaustion and immune senescence: two distinct pathways for HBV vaccine failure during HCV and/or HIV infection. Arch Immunol Ther Exp (Warsz). 2013;61:193–201. doi:10.1007/s00005-013-0219-0.
   PubMed Web of Science ®Google Scholar
• Pereira B, Xu XN, Akbar AN. Targeting inflammation and immunosenescence to improve vaccine responses in the elderly. Front Immunol. 2020;11:583019. doi:10.3389/fimmu.2020.583019.
   PubMed Web of Science ®Google Scholar
• Kotliarov Y, Sparks R, Martins AJ, Mulè MP, Lu Y, Goswami M, Kardava L, Banchereau R, Pascual V, Biancotto A, et al. Broad immune activation underlies shared set point signatures for vaccine responsiveness in healthy individuals and disease activity in patients with lupus. Nat Med. 2020;26:618–29. doi:10.1038/s41591-020-0769-8.
   PubMed Web of Science ®Google Scholar
• Tsang JS, Schwartzberg PL, Kotliarov Y, Biancotto A, Xie Z, Germain RN, Wang E, Olnes M, Narayanan M, Golding H, et al. Global analyses of human immune variation reveal baseline predictors of postvaccination responses. Cell. 2014;157:499–513. doi:10.1016/j.cell.2014.03.031.
   PubMed Web of Science ®Google Scholar
• Dienz O, Eaton SM, Bond JP, Neveu W, Moquin D, Noubade R, Briso EM, Charland C, Leonard WJ, Ciliberto G, et al. The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells. J Exp Med. 2009;206:69–78. doi:10.1084/jem.20081571.
   PubMed Web of Science ®Google Scholar
• Yang J, Sakai J, Siddiqui S, Lee RC, Ireland DDC, Verthelyi D, Akkoyunlu M. IL-6 impairs vaccine responses in neonatal mice. Front Immunol. 2018;9:3049. doi:10.3389/fimmu.2018.03049.
   PubMed Web of Science ®Google Scholar